Why Universal Technical Institute (UTI) is a Top Momentum Stock for the Long-Term

Zacks Investment Research highlights Universal Technical Institute (UTI) as a compelling momentum stock, citing its Zacks Rank #2 (Buy) rating and VGM Score of B. UTI's shares have risen 26.7% in the past four weeks, driven by upward earnings estimate revisions, with the fiscal 2025 consensus estimate increasing to $1.06 per share; the company also boasts a 59.8% average earnings surprise.

Analysis

Universal Technical Institute (UTI) is presented as a compelling investment, particularly for momentum-oriented investors, based on Zacks Investment Research's proprietary rating system. The company currently holds a Zacks Rank #2 (Buy) and a VGM Score of B, indicating a favorable outlook across value, growth, and momentum metrics. Notably, UTI's shares have appreciated by 26.7% over the past four weeks, a movement underpinned by positive revisions in its earnings estimates. Specifically, four analysts have revised their fiscal 2025 earnings estimates upwards in the last 60 days, resulting in the Zacks Consensus Estimate increasing by $0.05 to $1.06 per share. Furthermore, UTI has a strong track record of exceeding earnings expectations, evidenced by an average earnings surprise of 59.8%. Its Momentum Style Score of B further reinforces the positive trend in its stock price and earnings outlook, positioning it as a noteworthy stock within the Consumer Discretionary sector.

Key Decisions for Investors

• Investors with a momentum-driven strategy should consider UTI's recent 26.7% share price surge and its supportive Zacks Rank #2 (Buy) and B-grade Momentum Style Score.
• The consistent upward revisions in earnings estimates for fiscal 2025, now at a consensus of $1.06 per share, and UTI's significant average earnings surprise of 59.8%, suggest fundamental strength that could sustain positive performance.
• Given the combination of strong quantitative ratings from Zacks and positive analyst sentiment, UTI warrants consideration for inclusion on shortlists, particularly for those seeking exposure to companies with strong earnings momentum and recent price appreciation.